BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30019476)

  • 1. Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy.
    Huang H; Banerjee S; Sadler PJ
    Chembiochem; 2018 Aug; 19(15):1574-1589. PubMed ID: 30019476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design of Phosphorescent Iridium(III) Complexes for Selective Glutathione Sensing and Amplified Photodynamic Therapy.
    Huang T; Yu Q; Liu S; Zhang KY; Huang W; Zhao Q
    Chembiochem; 2019 Feb; 20(4):576-586. PubMed ID: 30267457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia.
    Lv W; Zhang Z; Zhang KY; Yang H; Liu S; Xu A; Guo S; Zhao Q; Huang W
    Angew Chem Int Ed Engl; 2016 Aug; 55(34):9947-51. PubMed ID: 27381490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal Complexes for Two-Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two-Photon Photosensitization of Cancer Cells under Near-IR Light.
    McKenzie LK; Sazanovich IV; Baggaley E; Bonneau M; Guerchais V; Williams JA; Weinstein JA; Bryant HE
    Chemistry; 2017 Jan; 23(2):234-238. PubMed ID: 27740703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
    Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
    Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
    Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
    Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells.
    Neelambaran N; Shamjith S; Murali VP; Maiti KK; Joseph J
    ACS Appl Bio Mater; 2023 Dec; 6(12):5776-5788. PubMed ID: 38061031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cyclometalated Ir
    Sudheesh KV; Jayaram PS; Samanta A; Bejoymohandas KS; Jayasree RS; Ajayaghosh A
    Chemistry; 2018 Aug; 24(43):10999-11007. PubMed ID: 29806867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Wireless Power-Transmission-Based Photodynamic Therapy for the Induction of Cell Death in Cancer Cells by Cyclometalated Iridium(III) Complexes.
    Yokoi K; Yasuda Y; Kanbe A; Imura T; Aoki S
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-soluble cyclometalated Ir(III) complexes as carrier-free and pure nanoparticle photosensitizers for photodynamic therapy and cell imaging.
    Tong X; Zhang L; Li L; Li Y; Yang Z; Zhu D; Xie Z
    Dalton Trans; 2020 Aug; 49(33):11493-11497. PubMed ID: 32789382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
    Negi M; Dixit T; Venkatesh V
    Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
    Yi S; Lu Z; Zhang J; Wang J; Xie Z; Hou L
    ACS Appl Mater Interfaces; 2019 May; 11(17):15276-15289. PubMed ID: 30968687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW; Pan ZY; Cai DH; Li Y; He L
    Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ir(III) and Ru(II) Complexes in Photoredox Catalysis and Photodynamic Therapy: A New Paradigm towards Anticancer Applications.
    Raza MK; Noor A; Samantaray PK
    Chembiochem; 2021 Dec; 22(23):3270-3272. PubMed ID: 34558773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared-emitting AIE multinuclear cationic Ir(III) complex-assembled nanoparticles for photodynamic therapy.
    Li L; Zhang L; Tong X; Li Y; Yang Z; Zhu D; Su Z; Xie Z
    Dalton Trans; 2020 Nov; 49(43):15332-15338. PubMed ID: 33119005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of pH-responsive cyclometalated iridium(III) complex and its application in the selective killing of cancerous cells.
    Yang P; Zhang S; Wang K; Qi H
    Dalton Trans; 2021 Nov; 50(46):17338-17345. PubMed ID: 34788356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-targeted iridium-based photosensitizers enhancing photodynamic therapy effect by disturbing cellular redox balance.
    Zhong M; He J; Zhang B; Liu Q; Fang J
    Free Radic Biol Med; 2023 Feb; 195():121-131. PubMed ID: 36581057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panchromatic Osmium Complexes for Photodynamic Therapy: Solutions to Existing Problems and New Questions.
    Glazer EC
    Photochem Photobiol; 2017 Oct; 93(5):1326-1328. PubMed ID: 28543667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
    Mo J; Mai Le NP; Priefer R
    Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of an iridium(iii)-complex-loaded MOF nanoplatform mediated with a dual-responsive polycationic polymer for photodynamic therapy and cell imaging.
    Zhang Y; Fu H; Chen S; Liu B; Sun W; Gao H
    Chem Commun (Camb); 2020 Jan; 56(5):762-765. PubMed ID: 31845680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.